TAK-771
Sponsors
Takeda
Conditions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Multifocal Motor Neuropathy (MMN)Primary Immunodeficiency Diseases (PID)
Phase 3
A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
CompletedNCT05084053
Start: 2022-01-19End: 2026-05-29Updated: 2026-06-24
A Study of TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)
CompletedNCT05150340
Start: 2022-01-24End: 2023-08-28Updated: 2024-11-25
A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants
CompletedNCT05513586
Start: 2022-09-13End: 2025-10-30Updated: 2026-05-19